Literature DB >> 20878417

Disorders of glucose metabolism-post mortem analyses in forensic cases: part I.

Cornelius Hess1, Frank Musshoff, Burkhard Madea.   

Abstract

In developed countries, diabetes is one of the ten most common causes of death. Post mortem diagnosis of glucose metabolism disorders can be difficult and vague because of the lack of characteristic morphological findings. Reviews of the literature are presented concerning biochemical problems in cases of unclear hyper- or hypoglycemia. After repetition of causes, frequency, and mortality of diabetic metabolism disorders, we give hints for the detection of diabetic ketoacidosis, hyperosmolar coma, insulinoma, and insulin- or oral diabetic-induced hypoglycemia. The first part discusses the analytes glucose and lactate, glycated proteins and oral antidiabetics, with special regard to their matrices post mortem, to reference concentrations, stability data and to analytic procedures that should be used in clinical or toxicological laboratories to detect diabetic metabolism disorders after death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878417     DOI: 10.1007/s00414-010-0509-6

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  109 in total

1.  Vitreous humor fructosamine concentrations in the autopsy diagnosis of diabetes mellitus.

Authors:  E Osuna; A García-Víllora; M D Pérez-Cárceles; J Conejero; J M Abenza; P Martínez; A Luna
Journal:  Int J Legal Med       Date:  1999       Impact factor: 2.686

Review 2.  Insulin analogues.

Authors:  Irl B Hirsch
Journal:  N Engl J Med       Date:  2005-01-13       Impact factor: 91.245

3.  Candidate reference methods for hemoglobin A1c based on peptide mapping.

Authors:  U Kobold; J O Jeppsson; T Dülffer; A Finke; W Hoelzel; K Miedema
Journal:  Clin Chem       Date:  1997-10       Impact factor: 8.327

Review 4.  C-peptide: an index of insulin secretion.

Authors:  O K Faber; C Binder
Journal:  Diabetes Metab Rev       Date:  1986

Review 5.  ACP Broadsheet no 137: April 1993. Obtaining samples at post mortem examination for toxicological and biochemical analyses.

Authors:  A R Forrest
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

6.  Factitious hyperinsulinemic hypoglycemia: confirmation of the diagnosis by a species-specific insulin radioimmunoassay.

Authors:  P G Walfish; D S Feig; W A Bauman
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

7.  Combined determination of glucose and fructosamine in vitreous humor as a post-mortem tool to identify antemortem hyperglycemia.

Authors:  Guillermo Vivero; Guillermo Vivero-Salmerón; Maria D Pérez Cárceles; Andrés Bedate; Aurelio Luna; Eduardo Osuna
Journal:  Rev Diabet Stud       Date:  2009-02-10

8.  Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control.

Authors:  R N Johnson; P A Metcalf; J R Baker
Journal:  Clin Chim Acta       Date:  1983-01-07       Impact factor: 3.786

9.  Can routinely combined analysis of glucose and lactate in vitreous humour be useful in current forensic practice?

Authors:  E A De Letter; M H Piette
Journal:  Am J Forensic Med Pathol       Date:  1998-12       Impact factor: 0.921

10.  Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up.

Authors:  G Grunberger; J L Weiner; R Silverman; S Taylor; P Gorden
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

View more
  14 in total

1.  Is the formula of Traub still up to date in antemortem blood glucose level estimation?

Authors:  Cristian Palmiere; Frank Sporkert; Paul Vaucher; Dominique Werner; Daniel Bardy; François Rey; Christelle Lardi; Christophe Brunel; Marc Augsburger; Patrice Mangin
Journal:  Int J Legal Med       Date:  2012-02-11       Impact factor: 2.686

Review 2.  Postmortem chemistry update part I.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-09-24       Impact factor: 2.686

3.  A case of instantaneous rigor?

Authors:  J Pirch; Y Schulz; M Klintschar
Journal:  Int J Legal Med       Date:  2013-06-26       Impact factor: 2.686

4.  Detection of RAGE expression and its application to diabetic wound age estimation.

Authors:  Xin-Yi Ji; Yang Chen; Guang-Hua Ye; Miao-Wu Dong; Ke-Zhi Lin; Jun-Ge Han; Xiang-Ping Feng; Xing-Biao Li; Lin-Sheng Yu; Yan-Yan Fan
Journal:  Int J Legal Med       Date:  2017-01-11       Impact factor: 2.686

5.  Clinical and forensic examinations of glycaemic marker methylglyoxal by means of high performance liquid chromatography-tandem mass spectrometry.

Authors:  Cornelius Hess; Bernd Stratmann; Wulf Quester; Diethelm Tschoepe; Burkhard Madea; Frank Musshoff
Journal:  Int J Legal Med       Date:  2012-07-21       Impact factor: 2.686

6.  Challenges in investigation of diabetes-related aviation fatalities-an analysis of 1491 subsequent aviation fatalities in USA during 2011-2016.

Authors:  Ilkka S Junttila; Alpo Vuorio; Bruce Budowle; Tanja Laukkala; Antti Sajantila
Journal:  Int J Legal Med       Date:  2018-07-04       Impact factor: 2.686

7.  Characteristics of fatal insulin overdoses.

Authors:  Lilli Stephenson; Corinna van den Heuvel; Melissa Humphries; Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2022-08-09       Impact factor: 2.456

8.  Assessment of Traub formula and ketone bodies in cause of death investigations.

Authors:  Terhi Keltanen; Antti Sajantila; Jukka U Palo; Teija Partanen; Tiina Valonen; Katarina Lindroos
Journal:  Int J Legal Med       Date:  2013-10-04       Impact factor: 2.686

9.  Preliminary results on the postmortem measurement of 3-beta-hydroxybutyrate in liver homogenates.

Authors:  Cristian Palmiere; Patrice Mangin; Dominique Werner
Journal:  Int J Legal Med       Date:  2013-05-31       Impact factor: 2.686

10.  Post-mortem analysis of lactate concentration in diabetics and metformin poisonings.

Authors:  T Keltanen; T Nenonen; R A Ketola; I Ojanperä; A Sajantila; K Lindroos
Journal:  Int J Legal Med       Date:  2015-09-01       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.